A new document provides a snapshot as to what various institutions across Europe have elected to teach at post-graduate level under a large and exciting variety of Nanotechnology Masters qualifications.
The Burnham Institute for Medical Research and the University of California, Santa Barbara have named leading biomedical researcher Jamey D. Marth director of a new joint Center for Nanomedicine that will be established at UCSB.
Dreidimensionale Zellkulturmodelle, Konvergierende Technologien und Siliziumkompatible Photonik - diese drei Themen stehen im Mittelpunkt der aktuellen Ausgabe des Newsletters 'future technologies update'.
Using a new detection system, scientists of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have unraveled the molecular mechanisms by which inflammations influence the glucose concentration in the blood.
A Queensland University of Technology researcher who has come up with a three-dimensional (3D) technology platform for biomedical research has received early-stage funding to accelerate the process of development to commercialisation.
Senior Metallurgical Engineer and Engineering Manager Dr. John Tartaglia of Stork Climax Research Services will be presenting a seminar titled 'Aspects of Electron Microscopy and Microanalysis', on Friday, August 21.
Modelling the fabrication processes for integrated circuits can slash production development time and costs by up to 40%. But as transistors, already at nano-scales, become ever smaller, researchers are modelling new worlds.
After more than 20 years with the Arkansas Small Business and Technology Development Center, Mildred Holley, manager of technology programs at the Arkansas Small Business Technology Development Center, is the new operations director of the University of Arkansas at Little Rock?s Nanotechnology Center.
Fibrin, the chief ingredient of blood clots, is a remarkably versatile polymer. On one hand, it forms a network of fibers -- a blood clot -- that stems the loss of blood at an injury site while remaining pliable and flexible. On the other hand, fibrin provides a scaffold for thrombi, clots that block blood vessels and cause tissue damage, leading to cardiovascular disease. The answer is a process known as protein unfolding.
Topics dealing with cost savings or subjects like 'Green MEMS' were popular in Tokyo. The fusion of microsystems technology with bio- and nanotechnology to hetero-functional, integrated devices is in focus of Japanese companies and institutes.